Guided Therapeutics (GTHP) Gross Profit (2012 - 2025)
Guided Therapeutics (GTHP) reported Gross Profit of $458000.0 for Q4 2025, up 23000.0% on a YoY basis from N/an in Q4 2024, and up 1208.57% sequentially from $35000.0 in Q3 2025.
Guided Therapeutics (GTHP) Gross Profit (2012 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 14 years of Gross Profit data on file, last reported at $458000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gross Profit rose 23000.0% year-over-year to $458000.0; the trailing twelve-month figure through Dec 2025 stood at $572000.0 (up 28500.0% YoY), and the FY2025 full-year result was $571000.0, up 28450.0% from the prior year.
- Gross Profit climbed to $458000.0 in Q4 2025, from $35000.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $458000.0 in Q4 2025 to a low of -$79000.0 in Q4 2022.
- A 5-year average of $35125.0 and a median of $4000.0 in 2022 frame the typical range for Gross Profit.
- Across the five-year window, Gross Profit slumped 292.68% in 2022 and soared 23000.0% in 2025, its largest moves.
- Tracing GTHP's Gross Profit over 5 years: stood at $41000.0 in 2021, then tumbled by 292.68% to -$79000.0 in 2022, then surged by 120.25% to $16000.0 in 2023, then slumped by 112.5% to -$2000.0 in 2024, then soared by 23000.0% to $458000.0 in 2025.
- Business Quant data shows GTHP's Gross Profit at $458000.0 in Q4 2025, $35000.0 in Q3 2025, and $79000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 458,000.00 |
| Dec 31, 2025 | 458,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Jun 30, 2023 | 11,000.00 |
| Jun 30, 2023 | 11,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Dec 31, 2022 | -79,000.00 |
| Dec 31, 2022 | -79,000.00 |